# CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™

Study · id `cardio:ct-nct03179800` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03179800](<https://clinicaltrials.gov/study/NCT03179800>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03179800

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 300 participants.

## Technical summary

Registry record NCT03179800. Randomized; triple masking; primary purpose treatment. Start 2017-10-19 (actual); primary completion 2025-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT03179800, source copy `cardio:ctgov-nct03179800-2024-07-18`, retrieved 2026-10-26)
- Started: 2017-10-19 (actual) (ClinicalTrials.gov record NCT03179800, source copy `cardio:ctgov-nct03179800-2024-07-18`, retrieved 2026-10-26)
- Primary completion: 2025-05 (anticipated) (ClinicalTrials.gov record NCT03179800, source copy `cardio:ctgov-nct03179800-2024-07-18`, retrieved 2026-10-26)
- Completion: 2025-05 (anticipated) (ClinicalTrials.gov record NCT03179800, source copy `cardio:ctgov-nct03179800-2024-07-18`, retrieved 2026-10-26)
- Countries: United States; France (ClinicalTrials.gov record NCT03179800, source copy `cardio:ctgov-nct03179800-2024-07-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03179800-2024-07-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
- Acronym: CALM-2
- Condition: Hypertension
- Condition: Resistant Hypertension
- Intervention (Device): MobiusHD
- Intervention (Other): Sham Implantation
- Lead sponsor: Vascular Dynamics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Resistant hypertension (`cardio:resistant-hypertension`)
- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)

## Provenance

Content hash: 0234f7d474e92168b2335067440719f2c1a6ee2fa42be4677b230b21c6636c00
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
